Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Grégory Ehx

7PUBLICATIONS
20CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Dec 24, 2025
Comparing a Novel Anti-BCMA NanoCAR with a Conventional ScFv-Based CAR for the Treatment of Multiple Myeloma.

Mégane Jassin, Chloé Onkelinx, Valentina Bocuzzi

|May 22, 2025
Tumor antigens preferentially derive from unmutated genomic sequences in melanoma and non-small cell lung cancer.

Anca Apavaloaei, Qingchuan Zhao, Leslie Hesnard

|Apr 16, 2024
Autophagy degrades immunogenic endogenous retroelements induced by 5-azacytidine in acute myeloid leukemia.

Nandita Noronha, Chantal Durette, Maxime Cahuzac

|Aug 15, 2023
BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens.

Maria Virginia Ruiz Cuevas, Marie-Pierre Hardy, Jean-David Larouche

|Mar 05, 2021
High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation.

Caroline Ritacco, Grégory Ehx, Céline Grégoire

|Jan 29, 2021
Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis.

Grégory Ehx, Caroline Ritacco, Muriel Hannon

Pageof 2

Frequent Collaborators

3 joint publications

Claude Perreault

2 joint publications

Nandita Noronha

2 joint publications

Maxime Cahuzac

2 joint publications

Jean-Philippe Laverdure

1 joint publications

Frédéric Baron

1 joint publications

Allan Sauvat

1 joint publications

Anca Apavaloaei

1 joint publications

Leslie Hesnard

1 joint publications

Mathieu Courcelles

1 joint publications

Mathieu Lajoie

Frequent Collaborators

3 joint publications

Claude Perreault

2 joint publications

Nandita Noronha

2 joint publications

Maxime Cahuzac

2 joint publications

Jean-Philippe Laverdure

Top Related Videos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on : Dec 13, 2018

6.8K
A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on : May 18, 2018

16.0K
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on : Jun 17, 2022

3.2K
See more related videos

Top Related Videos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on : Dec 13, 2018

6.8K
A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on : May 18, 2018

16.0K
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on : Jun 17, 2022

3.2K
See more related videos